Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis: “An Ally that Changes Allegiances”
- 17 January 2025
- book chapter
- Published by Springer Nature
- Vol. 1464, 373-395
Abstract
Breast cancer remission after treatment is sometimes long-lasting, but in about 30% of cases, there is a relapse after a so-called dormant state. Cellular cancer dormancy, the propensity of disseminated tumor cells (DTCs) to remain in a nonproliferative state for an extended period, presents an opportunity for therapeutic intervention that may prevent reawakening and the lethal consequences of metastatic outgrowth. Therefore, identification of dormant DTCs and detailed characterization of cancer cell-intrinsic and niche-specific [i.e., tumor microenvironment (TME) mediated] mechanisms influencing dormancy in different metastatic organs are of great importance in breast cancer. Several microenvironmental drivers of DTC dormancy in metastatic organs, such as the lung, bone, liver, and brain, have been identified using in vivo models and/or in vitro three-dimensional culture systems. TME induction and persistence of dormancy in these organs are mainly mediated by signals from immune cells, stromal cells, and extracellular matrix components of the TME. Alterations of the TME have been shown to reawaken dormant DTCs. Efforts to capitalize on these findings often face translational challenges due to limited availability of representative patient samples and difficulty in designing dormancy-targeting clinical trials. In this chapter, we discuss current approaches to identify dormant DTCs and provide insights into cell-extrinsic (i.e., TME) mechanisms driving breast cancer cell dormancy in distant organs.Keywords
This publication has 118 references indexed in Scilit:
- Cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate TumorAdvanced Science, 2023
- Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based studyInternational Journal of Cancer, 2018
- A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiDCytometry Part A, 2014
- The proinflammatory peptide substance P promotes blood–brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctionsInternational Journal of Cancer, 2013
- Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situInternational Journal of Cancer, 2011
- Stephen Paget and the ‘seed and soil’ theory of metastatic disseminationClinical and Experimental Medicine, 2006
- Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancyBreast Cancer Research and Treatment, 1996
- Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell linesClinical & Experimental Metastasis, 1993
- Metastatic patterns of renal carcinoma: An analysis of 687 necropsiesJournal of Cancer Research and Clinical Oncology, 1988
- ?Seed and soil? revisited: mechanisms of site-specific metastasisCancer and Metastasis Reviews, 1982